Not quite. PME management is obviously sane and grounded in reality. It can also be relied on to do what it says they will do. But yes, being honest with shareholders is a big and important help - and alas a novel concept for CUV and another biotech I'm silly enough to hold.
Not quite. PME management is obviously sane and grounded in...
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CUV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$15.24 |
Change
-0.140(0.91%) |
Mkt cap ! $763.5M | |||
| Open | High | Low | Value | Volume |
| $15.38 | $15.45 | $15.12 | $1.775M | 116.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 85 | $15.20 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $15.28 | 312 | 1 |
View Market Depth
| Last trade - 16.10pm 27/06/2024 (20 minute delay) ? |
| CUV (ASX) Chart |